Patient-reported outcomes for quality of life assessment in atrial fibrillation: A systematic review of measurement properties

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Kotecha, Dipak ^a,b,c   Ahmed, Amar ^a   Calvert, Melanie ^a   Lencioni, Mauro ^c   Terwee, Caroline B ^d   Lane, Deirdre A ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; ATRIAL FIBRILLATION; ATRIAL FIBRILLATION 6 QUESTIONNAIRE; ATRIAL FIBRILLATION EFFECT ON QUALITY OF LIFE QUESTIONNAIRE; ATRIAL FIBRILLATION QUALITY OF LIFE QUESTIONNAIRE; DISEASE SEVERITY; HUMAN; INTERNAL CONSISTENCY; QUALITY OF LIFE ASSESSMENT; QUALITY OF LIFE IN ATRIAL FIBRILLATION QUESTIONNAIRE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SYSTEMATIC REVIEW (TOPIC); TEST RETEST RELIABILITY; VALIDITY; PATIENT-REPORTED OUTCOME; QUALITY OF LIFE;

ATRIAL FIBRILLATION; HUMANS; PATIENT REPORTED OUTCOME MEASURES; QUALITY OF LIFE;

EID: 84994035358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165790     Document Type: Article

References (38)

1. Stewart S. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004; 90(3):286-92. doi: 10.1136/hrt.2002.008748 PMID: 14966048
2. Thrall G, Lane D, Carroll D., Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006; 119(5):448e1-19.
3. Waktare JE. Atrial fibrillation. Circulation. 2002; 106(1):14-6. PMID: 12093762
4. Aliot E, Botto GL, Crijns H.J., Kirchhof P. Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. Europace. 2014; 16(6):787-96. doi: 10.1093/europace/eut369 PMID: 24469433
5. Kirchhof P, Benussi S, Kotecha D., Ahlsson A, Atar D, Casadei B., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016; doi: 10.1093/eurheartj/ehw210 PMID: 27567408
6. Kotecha D, Holmes J, Krum H., Altman DG, Manzano L, Cleland JG, et al Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet. 2014; 384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8 PMID: 25193873
7. Ziff OJ, Lane DA, Samra M, Griffith M., Kirchhof P, Lip GY, et al Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ. 2015; 351:h4451. doi: 10.1136/bmj.h4451 PMID: 26321114
8. Caldeira D, David C, Sampaio C. Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials. Arch Cardiovasc Dis. 2012; 105(4):226-38. doi: 10.1016/j.acvd.2011.11.005 PMID: 22633297
9. Al-Khatib S.M., Allen LaPointe NM, Chatterjee R, Crowley MJ, Dupre M.E., Kong DF, et al. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2014; 160(11):760-73. doi: 10.7326/M13-1467 PMID: 24887617
10. Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol. 2008; 19(7):762-8. doi: 10.1111/j.1540-8167.2007.01091.x PMID: 18266667
11. de Vries M., Ouwendijk R, Kessels A.G., de Haan MW, Flobbe K, Hunink MG, et al Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg. 2005; 41(2):261-8. doi: 10.1016/j.jvs.2004.11.022 PMID: 15768008
12. Scholtes VA, Terwee CB, Poolman RW What makes a measurement instrument valid and reliable? Injury. 2011; 42(3):236-40. doi: 10.1016/j.injury.2010.11.042 PMID: 21145544
13. Terwee CB, Mokkink LB, Knol D.L., Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012; 21(4):651-7. doi: 10.1007/s11136-011-9960-1 PMID: 21732199
14. Terwee CB, Jansma EP, Riphagen I.I., de Vet HC. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009; 18(8):1115-23. doi: 10.1007/s11136-009-9528-5 PMID: 19711195
15. Yamashita T, Kumagi K, Koretsune Y, Mitamura H, Okumura K, Ogawa S, et al. A new method for evaluating quality of life specific to patients with atrial fibrillation: Atrial fibrillation quality of life questionnaire (AFQLQ). Jpn J Electrocardiology. 2003; 23:332-43.
16. Yamashita T, Komatsu K, Kumagi K., Uno K, Niwano S, Fujiki A., et al. Internal consistency and reproducibility of atrial fibrillation specific quality of life questionnaire (AFQLQ). Jpn J Electrocardiology. 2005; 25:488-94.
17. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007; 60(1):34-42. doi: 10.1016/j.jclinepi.2006.03.012 PMID: 17161752
18. Mokkink LB, Terwee CB, Patrick D.L., Alonso J., Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010; 63(7):737-45. doi: 10.1016/j.jclinepi.2010.02.006 PMID: 20494804
19. Mokkink LB, Terwee CB, Patrick D.L., Alonso J., Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010; 19(4):539-49. doi: 10.1007/s11136-010-9606-8 PMID: 20169472
20. Spertus J, Dorian P, Bubien R., Lewis S, Godejohn D, Reynolds M.R., et al. Development and validation of the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011; 4(1):15-25. doi: 10.1161/CIRCEp.110.958033 PMID: 21160035
21. Arribas F, Ormaetxe JM, Peinado R, Perulero N., Ramirez P, Badia X. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace. 2010; 12(3):364-70. doi: 10.1093/europace/eup421 PMID: 20056594
22. Badia X, Arribas F, Ormaetxe J.M., Peinado R., de Los Terreros MS. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health Qual Life Outcomes. 2007; 5:37. doi: 10.1186/1477-7525-5-37 PMID: 17610734
23. Braganca EO, Filho BL, Maria V.H., Levy D., de Paola AA. Validating a new quality of life questionnaire for atrial fibrillation patients. Int J Cardiol. 2010; 143(3):391-8. doi: 10.1016/j.ijcard.2009.03.087 PMID: 19395073
24. Harden M, Nystrom B, Kulich K., Carlsson J, Bengtson A, Edvardsson N. Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation. Health Qual Life Outcomes. 2009; 7:65. doi: 10.1186/1477-7525-7-65 PMID: 19604399
25. Harden M, Nystrom B, Bengtson A., Medin J, Frison L, Edvardsson N. Responsiveness of AF6, a new, short, validated, atrial fibrillation-specific questionnaire-symptomatic benefit of direct current cardioversion. J IntervCard Electrophysiol. 2010; 28(3):185-91. doi: 10.1007/s10840-010-9487-3 PMID: 20461545
26. World Health Organization. Measuring quality of life: the World Health Organization quality of life instruments. Available at: http://wwwwhoint/mental-health/media/68pdf [Accessed 01 Feb 2016]. 1997.
27. White J, Withers KL, Lencioni M, Carolan-Rees G, Wilkes A.R., Wood KA, et al. Cardiff cardiac ablation patient-reported outcome measure (C-CAP): validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK. Qual Life Res. 2015; doi: 10.1007/s11136-015-1194-1 PMID: 26659900
28. Mokkink LB, Terwee CB, Knol D.L., Stratford PW, Alonso J, Patrick DL, et al The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010; 10:22. doi: 10.1186/1471-2288-10-22 PMID: 20298572
29. Weldam SW, Schuurmans MJ, Liu R, Lammers JW Evaluation of Quality of Life instruments for use in COPD care and research: a systematic review. Int J Nurs Stud. 2013; 50(5):688-707. doi: 10.1016/j.ijnurstu.2012.07.017 PMID: 22921317
30. Dobson F, Hinman RS, Hall M, Terwee C.B., Roos EM, Bennell KL. Measurement properties of performance-based measures to assess physical function in hip and knee osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2012; 20(12):1548-62. doi: 10.1016/j.joca.2012.08.015 PMID: 22944525
31. Wheelwright S, Darlington AS, Hopkinson J.B., Fitzsimmons D., White A, Johnson CD. A systematic review of health-related quality of life instruments in patients with cancer cachexia. Support Care Cancer. 2013; 21(9):2625-36. doi: 10.1007/s00520-013-1881-9 PMID: 23797577
32. Elbers RG, Rietberg MB, van Wegen EE, Verhoef J, Kramer SF, Terwee C.B., et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties. Qual Life Res. 2012; 21(6):925-44. doi: 10.1007/s11136-011-0009-2 PMID: 22012025
33. Reeve BB, Wyrwich KW, Wu A.W., Velikova G., Terwee CB, Snyder CF, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013; 22(8):1889-905. doi: 10.1007/s11136-012-0344-y PMID: 23288613
34. US Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009; [Accessed 01-Jan-2016]: Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
35. Kotecha D, Piccini JP Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015; 36 (46):3250-7. doi: 10.1093/eurheartj/ehv513 PMID: 26419625
36. Moreira RS, Bassolli L, Coutinho E., Ferrer P, Braganca EO, Carvalho A.C., et al. Reproducibility and Reliability of the Quality of Life Questionnaire in Patients With Atrial Fibrillation. Arq Bras Cardiol. 2016; 106(3):171-81. doi: 10.5935/abc.20160026 PMID: 27027365
37. Dorian P, Burk C, Mullin C.M., Bubien R., Godejohn D, Reynolds MR, et al Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful? Am Heart J. 2013; 166(2):381-7.e8. doi: 10.1016/j.ahj.2013.04.015 PMID: 23895823
38. Institute of Cardiovascular Sciences; University of Birmingham, Chief Investigator Kotecha D. Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF). National Library of Medicine (US). 2015; NLM Identifier: NCT02391337 [Accessed 20-Nov-2015]: Available from: https://clinicaltrials.gov/ct2/show/NCT02391337